Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Q1 2025 vs. Q4 2024

How the institutions holding Medicus Pharma Ltd. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of MDCX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders37+4
Shares1.50M3.05M+1.55M (+103.0%)
Value$3.74M$11.4M+$7.61M (+203.4%)

New holders (5)

Institutions that held Medicus Pharma Ltd. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to MDCX in Q1 2025
InstitutionSharesValue% of portfolio
Armistice Capital, LLC1,266,000$4.71M0.13%
Private Advisor Group, LLC56,750$211.1K0.00%
UBS Group AG21,262$79.1K0.00%
Base Wealth Management LLC11,543$42.9K0.03%
Advisor Group Holdings, Inc.5,000$18.6K0.00%

Sold out (1)

Institutions that held Medicus Pharma Ltd. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of MDCX in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Royal Bank of Canada17,100$42.0K